7 июля, 2022

Pharmacogenetics n.154 of 31 October 2022

SIF Italian Society of Pharmacology

Pharmacogenetics n.154 of

Oncology
Impact of genetic polymorphisms in ABCB1 and ABCG2 transporters and in genes regulating the transport and metabolism of xenobiotics PXR and CAR on the clinical efficacy of dasatinib in chronic myeloid leukemiaNeuropsychiatry
Impact of NFIB and CYP1A gene variants on serum clozapine concentration – A retrospective naturalistic cohort study of 526 patients with known smoking information
Immunomodulation
HLA-DQA1 and DQB1 alleles are associated with acitretin response in psoriasis patients
Gastroenterology
NUDT15 variants strongly predict thiopurine-induced leukopenia in different Asian ethnicities: implications for screening in a diverse population.Decrease in Infliximab Concentrations in Patients With Inflammatory Bowel Disease Presenting with Variable Number Tandem Repeats in the Neonatal Fc Receptor or the Genotypic Variant HLADQA1*05G> A5G> A

— All rights reserved and for personal use
— Download the complete document in PDF format from the link at the bottom of the page

Access to the site is restricted and reserved for healthcare professionals

You have reached the maximum number of visits

Source — https://www.univadis.it/viewarticle/farmacogenetica-n154-del-31-ottobre-2022

TAGS:
Comments are closed.